Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Cancer Letters|March 29, 2021
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancerChia-Yi Lin, Kuo-Yen Huang, Yi-Chun Lin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2014
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerJih-Hsiang Lee, Yu-Lin Lin, Wei-Hsun Hsu, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2023
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health systemChing-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinomaChia-Ling Chang, Min-Shu Hsieh, Jin-Yuan Shih, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 26, 2020
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in TaiwanYuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2017
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgeryWen-Chi Yang, Furen Xiao, Jin-Yuan Shih, et al.
Food Science & Nutrition|April 8, 2026
Salidroside Ameliorates Polycystic Ovary Syndrome in Mice by Regulating the AKT/NF-κB/NLRP3-HAS2 AxisJing-Hang Li, Shu-Ming Shi, Li-Ying Liu, et al.
Food & Function|June 17, 2026
Chloroplasts as ingredients for food: a reviewDavid A Gray, Poramat Sutcharit, Jutarat Wattanakul, et al.
The Lancet. Respiratory Medicine|December 19, 2017
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic studyChia-Chi Lin, Jin-Yuan Shih, Chong-Jen Yu, et al.
Pageof 22